London Research and Pharmaceuticals

About London Research and Pharmaceuticals

London Research and Pharmaceuticals is an independent biopharmaceutical research and development molecular foundry located in Discovery Park at the University of Western Ontario. The organization serves the pharmaceutical industry by developing proprietary new drugs and candidates designed to offer improved efficacy and reduced toxicity compared to existing treatment options. The company maintains a diverse pharmaceutical pipeline featuring various small molecule projects. Specific candidates include LRP-661 for epilepsy, LRP-666 for pain, inflammation, and PTSD/anxiety, as well as projects targeting infectious diseases, psychiatric disorders, inflammatory bowel syndrome, and oncology. Their work involves the LRP Sulfate Platform and encompasses research into neurological conditions, anti-inflammatory agents, analgesics, and antibacterial treatments. The organization leverages scientific expertise in areas such as organic chemistry, medicinal chemistry, chemical engineering, formulation science, medical biophysics, and pharmacology. The team at London Research and Pharmaceuticals brings 250 years of combined research experience to their work. They provide leadership and advisory expertise across global pharmaceutical development, regulatory affairs for the FDA and EMA, governance, finance, and strategy. Their technical capabilities include small and large animal expertise, clinical trial expertise, and experience in organic and industrial chemistry. The company describes its approach as focusing on high-efficacy, low-toxicity solutions for health and wellness.